A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma.
Puduvalli VK, Wu J, Yuan Y, Armstrong TS, Vera E, Wu J, Xu J, Giglio P, Colman H, Walbert T, Raizer J, Groves MD, Tran D, Iwamoto F, Avgeropoulos N, Paleologos N, Fink K, Peereboom D, Chamberlain M, Merrell R, Penas Prado M, Yung WKA, Gilbert MR.
Puduvalli VK, et al. Among authors: raizer j.
Neuro Oncol. 2020 Oct 14;22(10):1505-1515. doi: 10.1093/neuonc/noaa062.
Neuro Oncol. 2020.
PMID: 32166308
Free PMC article.
Clinical Trial.